Mera Pharmaceuticals, Inc. (MRPI)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 15, 16:00
Mera Pharmaceuticals Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| October 31, 2011 | -0.0718M |
| July 31, 2011 | 0.0054M |
| April 30, 2011 | 0.0004M |
| January 31, 2011 | 0.1538M |
| October 31, 2010 | 0.1528M |
| July 31, 2010 | 0.1328M |
| April 30, 2010 | 0.0512M |
| January 31, 2010 | -0.0266M |
| October 31, 2009 | -0.0265M |
| July 31, 2009 | -0.0932M |
| April 30, 2009 | -0.0097M |
| January 31, 2009 | -0.0946M |
| October 31, 2008 | -0.1186M |
| July 31, 2008 | -0.0292M |
| April 30, 2008 | 0.0002M |
| January 31, 2008 | 0.0136M |
| October 31, 2007 | -0.0443M |
| July 31, 2007 | -0.0736M |
| April 30, 2007 | -0.1583M |
| January 31, 2007 | -0.2512M |
| October 31, 2006 | -0.2027M |
| July 31, 2006 | -0.2372M |
| April 30, 2006 | -0.3681M |
| January 31, 2006 | -0.4091M |
| October 31, 2005 | -0.5675M |
| Date | Value |
|---|---|
| July 31, 2005 | -0.5817M |
| April 30, 2005 | -0.6842M |
| January 31, 2005 | -1.050M |
| October 31, 2004 | -1.249M |
| July 31, 2004 | -1.141M |
| April 30, 2004 | -0.9929M |
| January 31, 2004 | -0.7152M |
| October 31, 2003 | -1.088M |
| July 31, 2003 | -0.0325M |
| April 30, 2003 | -0.8106M |
| January 31, 2003 | -0.889M |
| October 31, 2002 | -0.3772M |
| July 31, 2002 | -1.892M |
| April 30, 2002 | -1.790M |
| January 31, 2002 | -2.260M |
| October 31, 2001 | -3.037M |
| July 31, 2001 | -3.333M |
| April 30, 2001 | -3.295M |
| January 31, 2001 | -3.634M |
| October 31, 2000 | -3.342M |
| July 31, 2000 | -3.548M |
| April 30, 2000 | -3.653M |
| January 31, 2000 | -3.382M |
| October 31, 1999 | -3.248M |
| July 31, 1999 | -2.280M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |
| Sarepta Therapeutics, Inc. | 93.95M |
| Anixa Biosciences, Inc. | -7.376M |